Ms. Marshall has been in accounting and finance for over 25 years and completed two Masters Degrees at the University of Arizona. Ms. Marshall has worked as a CFO in Manufacturing, Healthcare and Pharma Research industries. As CFO of NuvOx, Ms. Marshall is responsible for accounting, is involved in the financing activities of the company and assists in business development. She teaches accounting in the Eller College of Management at the U of A.

Dr. Unger has founded three biotech companies. His first, ImaRx Pharmaceutical, developed 3 FDA approved drugs and was acquired by DuPont yielding a > 20x ROI. Dr. Unger’s second company, ImaRx Therapeutics, went public and performed clinical trials with a technology to treat stroke. Dr. Unger co-founded NuvOx. He is inventor on 113 issued US patents, a board-certified radiologist and professor of radiology and BME at the University of Arizona.

Dr. Wilson has over 20 years experience developing and commercializing Medical Products that continue to generate $2B/year. He effectively leads programs that build value for collaborators, shareholders and employees and has had leadership responsibility creating $4B worth of shareholder value in Biotechnology companies.

www.linkedin.com/pub/david-wilson/0/7a8/465/